Current Protein Identity:Q06455 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1WQ6 The tetramer structure of the nervy homolgy two (NHR2) domain of AML1-ETO is critical for AML1-ETO'S activity Deposited 2004-09-23 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 335–403(69 aa) Fragment:NHR2 domain
Chain B 335–403(69 aa) Fragment:NHR2 domain
Non-standard monomer:Yes (specific site not provided by mmCIF) Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.6;293 K;100mM Na citrate (pH 5.6), 100mM MgCl2, 30% MPD, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.00 Å R-free 0.270
2DJ8 Solution Structure of zf-MYND Domain of Protein CBFA2TI (Protein MTG8) Deposited 2006-03-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 449–450(2 aa) Fragment:zf-MYND
Not recorded ZN ZINC ION × 2 SOLUTION NMR
NMR measurement conditions pH 7;298 K;Ionic strength (raw mmCIF value) 120;Pressure ambient
NMR sample composition 0.95mM zf-MYND domain, U-13C, 15N; 20mM d-Tris_HCl (pH 7.0); 100mM NaCl; 1mM d-DTT, 0.02% NaN3; 0.05mM ZnCl2; 1mM IDA; 90% H2O, 10% D20 | 90% H2O, 10% D20
Resolution not provided
2KNH The Solution structure of the eTAFH domain of AML1-ETO complexed with HEB peptide Deposited 2009-08-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 119–216(98 aa) Fragment:eTAFH domain (UNP residues 119-216)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;303 K;Ionic strength (raw mmCIF value) 350;Pressure ambient
NMR sample composition 25 mM Bis-Tris, 1 mM EDTA, 350 mM sodium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
2KYG Structure of the AML1-ETO Nervy Domain - PKA(RIIa) complex and its contribution to AML1-ETO activity Deposited 2010-05-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 437–467(31 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 4;303 K;Ionic strength (raw mmCIF value) 0.0;Pressure ambient
NMR sample composition 2 mM [U-99% 13C; U-99% 15N] NHR3, 2 mM [U-99% 13C; U-99% 15N] PKA(RIIa), 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
2OD1 Solution structure of the MYND domain from human AML1-ETO Deposited 2006-12-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 510–559(50 aa) Fragment:MYND domain
Not recorded ZN ZINC ION × 2 SOLUTION NMR
NMR measurement conditions pH 6.8;303 K;Pressure 1
NMR sample composition 1-2mM protein, 25mM Bis-Tris, 5mM DTT, 50uM ZnCl2, 95% H20, 5% D2O | 95% H20, 5% D2O
Resolution not provided
2ODD Solution structure of the MYND domain from AML1-ETO complexed with SMRT, a corepressor Deposited 2006-12-22 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 510–559(50 aa) Fragment:MYND domain (AML1-ETO, residues 658-707)
Not recorded ZN ZINC ION × 2 SOLUTION NMR
NMR measurement conditions pH 6.8;303 K;Pressure 1
NMR sample composition 2mM SMRT-MYND, 25mM Bis-Tris, pH 6.8, 50uM ZnCl2, 1mM DTT, 95%H2O, 5% D2O | 95% H2O/5% D2O
Resolution not provided
2PP4 Solution Structure of ETO-TAFH refined in explicit solvent Deposited 2007-04-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 119–225(107 aa) Fragment:TAFH domain, residues 119-225
Mutation:F136Y No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;293 K;Pressure ambient
NMR sample composition 1.1 mM protein, 200 mM phosphate buffer, 95% H2O, 5% D2O | 95% H2O/5% D2O
Resolution not provided
4JOL Complex structure of AML1-ETO NHR2 domain with HEB fragment Deposited 2013-03-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 338–400(63 aa) Fragment:NHR2 domain of AML1-ETO (unp residues 338-400)
Chain C 338–400(63 aa) Fragment:NHR2 domain of AML1-ETO (unp residues 338-400)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 mM Tris, 20% ETHANOL, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.91 Å R-free 0.252
4JOL Complex structure of AML1-ETO NHR2 domain with HEB fragment Deposited 2013-03-18 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 338–400(63 aa) Fragment:NHR2 domain of AML1-ETO (unp residues 338-400)
Chain D 338–400(63 aa) Fragment:NHR2 domain of AML1-ETO (unp residues 338-400)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 mM Tris, 20% ETHANOL, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.91 Å R-free 0.252